ST. ALEXIUS HOSPITAL
1. Target Overview & Investment Thesis
ST. ALEXIUS HOSPITAL is a 147-bed under-performing / distressed in ST. LOUIS, MO with $45.4M in net patient revenue and a -38.9% operating margin. The hospital serves a payer mix of 24.9% Medicare, 32.0% Medicaid, and 43.1% commercial.
Thesis: Undervalued. Our ML models identify $3.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -38.9% to -31.5% (+736bps).
| Net Revenue HCRIS | $45.4M |
| Current EBITDA COMPUTED | $-17.7M |
| Operating Margin COMPUTED | -38.9% |
| Occupancy HCRIS | 19.2% |
| Revenue / Bed COMPUTED | $309K |
| Net-to-Gross HCRIS | 21.6% |
| Distress Probability ML | 62.4% |
2. Market Context & Competitive Position
MO has 138 Medicare-certified hospitals with a median operating margin of -6.2%. The target's margin of -38.9% places it below the state median. Among 39 size-comparable peers (74-294 beds), the median margin is -1.3%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (74-294), prioritizing same-state peers. 39 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| ST. ALEXIUS HOSPITAL (Target) | MO | 147 | $45.4M | -38.9% |
| SAINT FRANCIS MEDICAL CENTER | MO | 282 | $556.6M | -1.3% |
| UNIVERSITY HEALTH TRUMAN MED C | MO | 258 | $540.8M | -13.5% |
| AMEND 1 CENTERPOINT MEDICAL CE | MO | 265 | $378.8M | 19.2% |
| BOONE HOSPITAL CENTER | MO | 278 | $346.5M | -22.5% |
| CHRISTIAN HOSPITAL NORTHEAST | MO | 267 | $340.9M | -6.6% |
| SOUTHEASTHEALTH | MO | 232 | $335.2M | -15.2% |
| ST. LUKES EAST - LEES SUMMIT | MO | 216 | $318.1M | -5.8% |
| LIBERTY HOSPITAL | MO | 199 | $303.2M | -3.1% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $3.3M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $954K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $909K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $900K | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $553K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $29K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-17.7M |
| + RCM Uplift | +$3.3M |
| Pro Forma EBITDA | $-14.3M |
| Current Margin | -38.9% |
| Pro Forma Margin | -31.5% |
| WC Released (1x) | $1.7M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-27.2M | $-83.1M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-27.2M | $-100.2M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-24.5M | $-98.0M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-24.5M | $-114.2M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-29.9M | $-91.0M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-29.9M | $-109.8M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Medium | Elevated Medicaid exposure (32.0%) | Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims |
| Medium | Low occupancy | At 19.2%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case |
| High | Elevated distress probability | Model estimates 62.4% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 39 hospitals with 74-294 beds
- Same-state prioritization (n=40)
- Comp margins: P25=-13.1% / P50=-1.3% / P75=8.7%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.